Home
CTOR
CTOR News

Latest CITIUS ONCOLOGY INC (CTOR) News on March 29, 2025

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

PR Newswire

2 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

PR Newswire

3 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Citius Oncology to explore strategic alternatives

TipRanks

3 months ago

Citius Oncology to explore strategic alternatives

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

PR Newswire

3 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital

TipRanks

3 months ago

Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

PR Newswire

3 months ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

PR Newswire

3 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Citius Oncology, Inc.'s (NASDAQ:CTOR) Path To Profitability

Simply Wall St.

4 months ago

Citius Oncology, Inc.'s (NASDAQ:CTOR) Path To Profitability

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

7 months ago

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Share on Social Networks: